Manhattan Research Releases Physician Digital Media Planning Guide
While most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites - such as the WebMD Professional Network, the New England Journal of Medicine, or specialty specific sites - more frequently than they use pharma-owned properties. Message on the occasion of World AIDS Day
Hope because significant progress has been made towards universal access. New HIV infections have dropped. Fewer children are born with HIV. And more than 4 million people are on treatment.
EU-funded researchers use gene therapy to slow brain disease
85% of Online Europeans Use the Internet for Health Information
In 2009, 85% of online Europeans in the United Kingdom, Germany, France, Italy, and Spain turn to the Internet and other technologies for health and prescription drug information, according to the latest Cybercitizen Health® Europe v9.0 study from healthcare and pharmaceutical market research company Manhattan Research. The collaboratively-edited Wikipedia again proves to be a top online health resource for consumers in all of the countries surveyed. International Diabetes Federation drives global action ahead of World Diabetes Day
European Partnership for Action against Cancer
At the end of September month, in Brussels, over 300 cancer organisations, patients and cancer survivors, health professionals, researchers, health authorities and health ministers gather to mark the official launch of the European Partnership for Action against Cancer. More Pharma News ...
Business & Industry
- Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
- Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
- Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
- Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant
- GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab
Research & Development
- New study suggests two paths toward ‘super immunity’ to COVID-19
- The cellular response that protects pigs from COVID-19
- An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
- Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
- WHO recommends two new drugs to treat patients with COVID-19
- Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19
- COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
Conferences & Events
- SMi Group's 13th Annual Conference: RNA Therapeutics 2022
- SMi's 5th Annual 3D Cell Culture Conference
- New vaccine ingredient shows promise
- Modernise your Medical Affairs Insight Management with ViiV Healthcare, Eisai, ASC Therapeutics and Within3
- Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
Regulatory Affairs
- FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults
- FDA authorizes first oral antiviral for treatment of COVID-19
- FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases